Correction: The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-2684
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer

Clinical Cancer Research
Cancer ResearchOncology
2012English

Chimeric Antigen Receptors for T Cell Immunotherapy: Current Understanding and Future Directions

Journal of Gene Medicine
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2012English

New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer

Journal of Oncology
Oncology
2010English

Pcn301 - Health Technology Assessment for Chimeric Antigen Receptor (Car) T-Cell Therapies for Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

214. Design of Multifunctional Chimeric Antigen Receptors for T Cell Cancer Immunotherapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Chimeric Antigen Receptor T Cell Therapies for Multiple Myeloma

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

The Other Face of Chimeric Antigen Receptors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

Author Correction: Anti-Bcma Chimeric Antigen Receptors With Fully Human Heavy-Chain-Only Antigen Recognition Domains

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2020English

Targeted Therapies for Pancreatic Cancer

Cancers
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy